@inproceedings{inproceedings, title  = {{Cost effectiveness of adalimumab (HUMIRA (TM), Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA)}},

 url = {{}},

 year = {{2003}},

 month = {{9}},

 author = {{Bansback NJ and Brennan A and Sengupta N and Chang KY}},

 volume = {{48}},

 journal = {{ARTHRITIS AND RHEUMATISM}},

 issue = {{9}},

 pages = {{S215-S215}},

 note = {{Accessed on 2024/12/22}}}